Wellington Management Group LLP Sells 391,872 Shares of Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Wellington Management Group LLP reduced its stake in Sabra Healthcare REIT by 12.2% in the first quarter, holding approximately 1.18% of the company at a value of $49.1 million after selling 391,872 shares.
• Sabra Healthcare REIT reported a quarterly earnings per share (EPS) of $0.38, beating the consensus estimate of $0.36, with revenue increasing by 7.4% year-over-year to $189.15 million.
• The company declared a quarterly dividend of $0.30 per share, representing a dividend yield of 6.1%, with a payout ratio of 157.89%.

Wellington Management Group LLP lowered its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 12.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,813,170 shares of the real estate investment trust's stock after selling 391,872 shares during the period. Wellington Management Group LLP owned approximately 1.18% of Sabra Healthcare REIT worth $49,146,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. Versor Investments LP acquired a new stake in Sabra Healthcare REIT in the first quarter valued at about $1,934,000. Ethos Financial Group LLC acquired a new stake in Sabra Healthcare REIT in the first quarter valued at about $1,150,000. State of New Jersey Common Pension Fund D boosted its stake in Sabra Healthcare REIT by 3.6% in the first quarter. State of New Jersey Common Pension Fund D now owns 254,958 shares of the real estate investment trust's stock valued at $4,454,000 after buying an additional 8,780 shares in the last quarter. American Century Companies Inc. boosted its stake in Sabra Healthcare REIT by 4.2% in the first quarter. American Century Companies Inc. now owns 54,823 shares of the real estate investment trust's stock valued at $958,000 after buying an additional 2,220 shares in the last quarter. Finally, Aberdeen Group plc boosted its stake in Sabra Healthcare REIT by 0.5% in the first quarter. Aberdeen Group plc now owns 904,857 shares of the real estate investment trust's stock valued at $15,808,000 after buying an additional 4,167 shares in the last quarter. Institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Down 1.0%

Shares of NASDAQ SBRA traded down $0.20 during midday trading on Friday, hitting $19.11. 2,586,825 shares of the stock traded hands, compared to its average volume of 2,763,639. The company has a market cap of $4.58 billion, a PE ratio of 25.15, a P/E/G ratio of 1.54 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a one year low of $15.60 and a one year high of $20.03. The business has a 50 day moving average price of $18.56 and a two-hundred day moving average price of $17.78. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. The company had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.Sabra Healthcare REIT's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

Analysts Set New Price Targets

A number of analysts have recently commented on SBRA shares. BMO Capital Markets lifted their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday. Wells Fargo & Company lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday. JMP Securities lifted their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. Finally, Scotiabank lifted their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $20.43.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.